Ambroxol, 20 tablets, Egis Pharmaceutical

Ambroxol, 30 mg, 20 tablets, Egis Pharmaceutical

Indications :
Ambroxol Egis 30 mg tablets is indicated as secretolytic therapy:
- in chronic bronchopulmonary diseases associated with abnormal mucus secretion and impaired mucus transport;
- in acute bronchial diseases and acute episodes of chronic bronchopneumopathy.
Also, Ambroxol Egis 30 mg tablets is indicated pre- and postoperatively.

Contraindications:
Do not use Ambroxol Egis:
- if you are allergic to ambroxol or any of the other components of this medicine.

Precautions:
Before using Ambroxol Egis, talk to your doctor or pharmacist.

Pregnancy, breast-feeding and fertility:
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Studies in laboratory animals have not shown a teratogenic effect. However, it is recommended not to administer ambroxol hydrochloride to pregnant women.
Ambroxol is excreted in breast milk, so it is not recommended during breastfeeding.

Driving vehicles and using machines:
Since, very rarely, headaches and dizziness have been described during treatment with Ambroxol Egis 30 mg tablets, caution is recommended in patients who drive vehicles or use machines.

Administration method:
Always use this medicine exactly as your doctor or pharmacist has told you. Talk to your doctor or pharmacist if you are not sure.

Adults and children over 12 years:
The recommended dose is 1 Ambroxol Egis tablet 3 times a day (90 mg ambroxol hydrochloride per day), in the first 2-3 days; then the dose is reduced to 1 Ambroxol Egis tablet 2 times a day (60 mg ambroxol hydrochloride per day)

In case of severe renal insufficiency, due to the accumulation of ambroxol metabolites resulting from metabolism in the liver, the maintenance dose should be reduced accordingly, and the interval between doses should be extended.
Tablets should be taken whole with liquids, after meals. The mucolytic effect is potentiated by the intake of fluids.

If you have any further questions about this medicine, ask your doctor or pharmacist.

Composition:
- The active substance is ambroxol. One tablet contains ambroxol hydrochloride 30 mg.
- The other components are: lactose monohydrate, microcrystalline cellulose, povidone K 30, sodium starch glycolate type A, magnesium stearate.

Presentation :
20 tablets

Warning:
Read the leaflet carefully and completely before you start using this medicine because it contains important information for you.